The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Therapy for Inherited Genetic Disorders Market Research Report 2025
Synopsis
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
The global Gene Therapy for Inherited Genetic Disorders market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Inherited Genetic Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Inherited Genetic Disorders.
Report Scope
The Gene Therapy for Inherited Genetic Disorders market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy for Inherited Genetic Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy for Inherited Genetic Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
Segment by Type
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Segment by Application
Hospital
Clinic
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy for Inherited Genetic Disorders companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
The global Gene Therapy for Inherited Genetic Disorders market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Inherited Genetic Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Inherited Genetic Disorders.
Report Scope
The Gene Therapy for Inherited Genetic Disorders market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy for Inherited Genetic Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy for Inherited Genetic Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.
Segment by Type
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
Segment by Application
Hospital
Clinic
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy for Inherited Genetic Disorders companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Eye Disorders
1.2.3 Hematological Disorders
1.2.4 Central Nervous System Disorders
1.2.5 Muscular Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Perspective (2019-2030)
2.2 Gene Therapy for Inherited Genetic Disorders Growth Trends by Region
2.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy for Inherited Genetic Disorders Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy for Inherited Genetic Disorders Market Dynamics
2.3.1 Gene Therapy for Inherited Genetic Disorders Industry Trends
2.3.2 Gene Therapy for Inherited Genetic Disorders Market Drivers
2.3.3 Gene Therapy for Inherited Genetic Disorders Market Challenges
2.3.4 Gene Therapy for Inherited Genetic Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue
3.1.1 Global Top Gene Therapy for Inherited Genetic Disorders Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Inherited Genetic Disorders Revenue
3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio
3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2023
3.5 Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
3.7 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type
4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2025-2030)
5 Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application
5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
6.2 North America Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
6.4 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
7.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
9.2 Latin America Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Detail
11.1.2 BioMarin Pharmaceutical Inc. Business Overview
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.1.4 BioMarin Pharmaceutical Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.1.5 BioMarin Pharmaceutical Inc. Recent Development
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Detail
11.2.2 bluebird bio Inc. Business Overview
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.2.4 bluebird bio Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.2.5 bluebird bio Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Introduction
11.3.4 Novartis AG Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.3.5 Novartis AG Recent Development
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Detail
11.4.2 Orchard Therapeutics Plc Business Overview
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Introduction
11.4.4 Orchard Therapeutics Plc Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.4.5 Orchard Therapeutics Plc Recent Development
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Detail
11.5.2 Spark Therapeutics Inc. Business Overview
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Introduction
11.5.4 Spark Therapeutics Inc. Revenue in Gene Therapy for Inherited Genetic Disorders Business (2019-2024)
11.5.5 Spark Therapeutics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
